GLMD (Galmed Pharmaceuticals) Days Payable: 0.00 (As of Dec. 2025)

What is Galmed Pharmaceuticals Days Payable?

Galmed Pharmaceuticals GLMD +2.71% 27 Days Payable is 0.00 as of Dec. 2025. GuruFocus rates GLMD with a GF Score™ of 27/100. The stock has 2 warning signs investors should review. Among 708 Biotechnology companies, Galmed Pharmaceuticals ranks worse than 141242.8% on this metric.

Galmed Pharmaceuticals's average Accounts Payable for the three months ended in Dec. 2025 was $1.84 Mil. Galmed Pharmaceuticals's Cost of Goods Sold for the three months ended in Dec. 2025 was $0.00 Mil.

The historical rank and industry rank for Galmed Pharmaceuticals's Days Payable or its related term are showing as below:

GLMD's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 113.56
* Ranked among companies with meaningful Days Payable only.

Galmed Pharmaceuticals's Days Payable stayed the same from Dec. 2024 (0.00) to Dec. 2025 (0.00). stayed the same

Galmed Pharmaceuticals Days Payable Related Terms

Galmed Pharmaceuticals Days Payable Historical Data

* Premium members only.

The historical data trend for Galmed Pharmaceuticals's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Galmed Pharmaceuticals Days Payable Chart

Galmed Pharmaceuticals Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Days Payable

Get a 7-Day Free Trial

0.00

Galmed Pharmaceuticals Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25
Days Payable	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

GLMD vs RNAZ, ARTL, CDT: Days Payable Comparison

For the Biotechnology subindustry, Galmed Pharmaceuticals's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Galmed Pharmaceuticals Days Payable vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Galmed Pharmaceuticals's Days Payable distribution charts can be found below:

* The bar in red indicates where Galmed Pharmaceuticals's Days Payable falls into.

Save Embed

27GF Score

Galmed Pharmaceuticals Ltd GLMD

Days Payable is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Galmed Pharmaceuticals Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Galmed Pharmaceuticals's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as

	Days Payable (A: Dec. 2025 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2024 )	+	Accounts Payable (A: Dec. 2025 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2025 )	*	Days in Period
=	( (1.308	+	2.003)	/	2 )	/	0	*	365
=	1.6555					/	0	*	365
=	N/A

Galmed Pharmaceuticals's Days Payable for the quarter that ended in Dec. 2025 is calculated as:

	Days Payable (Q: Dec. 2025 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Sep. 2025 )	+	Accounts Payable (Q: Dec. 2025 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2025 )	*	Days in Period
=	( (1.674	+	2.003)	/	2 )	/	0	*	365 / 4
=	1.8385					/	0	*	365 / 4
=	N/A

Frequently Asked Questions Learn more about Days Payable →

What does a Days Payable of 0.00 mean?

Galmed Pharmaceuticals (GLMD) has a Days Payable of 0.00 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Galmed Pharmaceuticals and its competitors. According to the industry distribution chart, Galmed Pharmaceuticals ranks #999999 out of 708 companies in the Biotechnology industry.

Is Galmed Pharmaceuticals' Days Payable too high?

Galmed Pharmaceuticals' current Days Payable is 0.00. Based on the distribution chart, Galmed Pharmaceuticals ranks #999999 out of 708 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Galmed Pharmaceuticals has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.

How does Galmed Pharmaceuticals' Days Payable compare to RNAZ and ARTL?

According to the Biotechnology industry distribution chart, Galmed Pharmaceuticals ranks #999999 out of 708 companies for Days Payable. This places Galmed Pharmaceuticals in the lower half of its industry. The industry median Days Payable is 113.56. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Days Payable for a Biotechnology company?

The median Days Payable among Biotechnology companies is 113.56, based on 708 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Days Payable mean?

A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Galmed Pharmaceuticals and its competitors. For the Biotechnology industry, the median Days Payable is 113.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Galmed Pharmaceuticals's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Galmed Pharmaceuticals stock overvalued right now?

Galmed Pharmaceuticals (GLMD) has a current Days Payable of 0.00. The current Days Payable is 0.00. Galmed Pharmaceuticals' overall GF Score™ is 27/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Days Payable calculated?

Days Payable is calculated from a company's financial statements. For Galmed Pharmaceuticals (GLMD), the current Days Payable is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Galmed Pharmaceuticals Business Description

Industry Healthcare Biotechnology

Comparable Companies RNAZ ARTL CDT PULM ADIL MBIO DCOY MTNB DRMA RVPH VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Address c/o Meitar Law Offices, 16 Abba Hillel Road, Ramat Gan, ISR, 5250608

Website https://www.galmedpharma.com

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. The company focuses on the development of Aramchol for combination therapy for GI oncological indications. The company is actively pursuing opportunities in the biotech and medtech spaces to expand and diversify its product pipeline targeting GI, cardiometabolic indications and other product candidates.

27GF Score

Get the complete analysis for GLMD

Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.59

Price

View GLMD Analysis

See Days Payable data for all stocks →